FindTrial
Sign In

To assess the occurrence of heartburn/regurgitation (Gastroesophageal Reflux) in Achalasia patients who underwent Operation

Gastroesophageal Reflux after Laparoscopic Hellerâ??s Cardiomyotomy and Antireflux Procedure in Achalasia Cardia: Objective and Subjective Evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036909
Enrollment
20
Registered
2021-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis

Interventions

None listed

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of achalasia who underwent LHCM with an ARP at least 6 months ago

Exclusion criteria

Exclusion criteria: Any contraindication to 24-hour pH study Hiatal hernia greater than or equal to 3 cm Sigmoid esophagus Esophageal diverticulum Patient not consenting to participate in the study

Design outcomes

Primary

MeasureTime frame
To objectively assess the prevalence of gastroesophageal reflux in achalasia patients who underwent laparoscopic Hellerâ??s cardiomyotomy (LHCM) with an antireflux procedure (ARP) using 24-hour pH studyTimepoint: more than 6 months—

Secondary

MeasureTime frame
To correlate the symptomatic heart burn with 24-hour pH studyTimepoint: more than 6 months;To evaluate the prevalence of gastroesophageal reflux amongst the different antireflux proceduresTimepoint: more than 6 months—

Countries

India

Contacts

Public ContactDr Dharmendra Kumar

All India Institute of medical Sciences

drrajinderparshad.aiims@gmail.com9868397715

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026